CL2010000749A1 - Mesoporous zinc oxide powder having average size in number of zinc oxide aggregates of at least 0.8 micrometer or at least 1 micrometer; and method of producing said powder. - Google Patents

Mesoporous zinc oxide powder having average size in number of zinc oxide aggregates of at least 0.8 micrometer or at least 1 micrometer; and method of producing said powder.

Info

Publication number
CL2010000749A1
CL2010000749A1 CL2010000749A CL2010000749A CL2010000749A1 CL 2010000749 A1 CL2010000749 A1 CL 2010000749A1 CL 2010000749 A CL2010000749 A CL 2010000749A CL 2010000749 A CL2010000749 A CL 2010000749A CL 2010000749 A1 CL2010000749 A1 CL 2010000749A1
Authority
CL
Chile
Prior art keywords
zinc oxide
micrometer
powder
producing
average size
Prior art date
Application number
CL2010000749A
Other languages
Spanish (es)
Inventor
Mccormick Geoffrey Trotter Paul
Original Assignee
Antaria Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Antaria Ltd filed Critical Antaria Ltd
Publication of CL2010000749A1 publication Critical patent/CL2010000749A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/27Zinc; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0241Containing particulates characterized by their shape and/or structure
    • A61K8/0275Containing agglomerated particulates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/26Optical properties
    • A61K2800/262Transparent; Translucent
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41Particular ingredients further characterized by their size
    • A61K2800/412Microsized, i.e. having sizes between 0.1 and 100 microns

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Cosmetics (AREA)
  • Inorganic Compounds Of Heavy Metals (AREA)
  • Silicates, Zeolites, And Molecular Sieves (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Polvo mesoporoso de óxido de zinc que tiene tamaño promedio en número de agregados de óxido de zinc de por lo menos 0,8 micrómetros o por lo menos 1 micrómetro; y método para producir dicho polvo.Mesoporous zinc oxide powder having number average size of zinc oxide aggregates of at least 0.8 microns or at least 1 micron; and method of producing said powder.

CL2010000749A 2008-01-11 2010-07-13 Mesoporous zinc oxide powder having average size in number of zinc oxide aggregates of at least 0.8 micrometer or at least 1 micrometer; and method of producing said powder. CL2010000749A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US639808P 2008-01-11 2008-01-11
PCT/US2009/030725 WO2009089523A1 (en) 2008-01-11 2009-01-12 Visibly transparent uv photoprotective compositions

Publications (1)

Publication Number Publication Date
CL2010000749A1 true CL2010000749A1 (en) 2011-03-11

Family

ID=40853488

Family Applications (2)

Application Number Title Priority Date Filing Date
CL2010000749A CL2010000749A1 (en) 2008-01-11 2010-07-13 Mesoporous zinc oxide powder having average size in number of zinc oxide aggregates of at least 0.8 micrometer or at least 1 micrometer; and method of producing said powder.
CL2010000748A CL2010000748A1 (en) 2008-01-11 2010-07-13 A broad spectrum UV photoprotective composition comprising mesoporous zn oxide aggregates having average aggregate size of at least 0.8 µm dispersed in a carrier and said composition is visibly transparent; and method to protect mammalian skin and hair from UV radiation.

Family Applications After (1)

Application Number Title Priority Date Filing Date
CL2010000748A CL2010000748A1 (en) 2008-01-11 2010-07-13 A broad spectrum UV photoprotective composition comprising mesoporous zn oxide aggregates having average aggregate size of at least 0.8 µm dispersed in a carrier and said composition is visibly transparent; and method to protect mammalian skin and hair from UV radiation.

Country Status (14)

Country Link
EP (1) EP2244691A1 (en)
JP (1) JP2011509940A (en)
KR (1) KR20100120656A (en)
CN (1) CN101932303A (en)
AU (1) AU2009203992A1 (en)
BR (1) BRPI0906493A2 (en)
CA (1) CA2710958A1 (en)
CL (2) CL2010000749A1 (en)
EA (1) EA201001128A1 (en)
IL (1) IL206911A0 (en)
MX (1) MX2010007498A (en)
NZ (1) NZ587282A (en)
WO (1) WO2009089523A1 (en)
ZA (1) ZA201005490B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI1005345B1 (en) * 2010-04-13 2017-06-13 U.S. Cosmetics Corporation Strengthening composition of sun protection factor
FR2977490B1 (en) * 2011-07-07 2014-03-21 Oreal PHOTOPROTECTIVE COMPOSITION
EP2709613B2 (en) 2011-09-16 2020-08-12 Gilead Pharmasset LLC Methods for treating hcv
EP2950786B1 (en) 2013-01-31 2019-11-27 Gilead Pharmasset LLC Combination formulation of two antiviral compounds
EP3036003A1 (en) * 2013-08-22 2016-06-29 Merck Patent GmbH Diffusion pigments in phototherapy
US10172783B2 (en) * 2014-06-04 2019-01-08 L'oreal High UV protection alcohol-free anhydrous clear system
US12605314B2 (en) 2018-03-23 2026-04-21 LCS Advanced Solutions, LLC Broad-spectrum, mineral, photoprotective compositions
EP3873480B1 (en) * 2018-10-30 2024-08-14 VeganicSKN Limited Anti-acne composition
US12083199B2 (en) 2019-09-10 2024-09-10 LCS Advanced Solutions, LLC Mineral, anhydrous, broad-spectrum sunscreen
EP4353328A3 (en) 2022-10-15 2024-05-22 LCS Advanced Solutions, LLC Structurally diverse, stable, and radiation-protective particle matrix sunscreen and cosmetic compositions and related methods

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5441726A (en) * 1993-04-28 1995-08-15 Sunsmart, Inc. Topical ultra-violet radiation protectants
AUPP355798A0 (en) * 1998-05-15 1998-06-11 University Of Western Australia, The Process for the production of ultrafine powders

Also Published As

Publication number Publication date
CN101932303A (en) 2010-12-29
BRPI0906493A2 (en) 2017-06-13
JP2011509940A (en) 2011-03-31
EA201001128A1 (en) 2011-02-28
KR20100120656A (en) 2010-11-16
ZA201005490B (en) 2011-04-28
CL2010000748A1 (en) 2011-03-11
IL206911A0 (en) 2010-12-30
AU2009203992A1 (en) 2009-07-16
WO2009089523A1 (en) 2009-07-16
MX2010007498A (en) 2010-10-15
NZ587282A (en) 2012-09-28
CA2710958A1 (en) 2009-07-16
EP2244691A1 (en) 2010-11-03

Similar Documents

Publication Publication Date Title
CL2010000749A1 (en) Mesoporous zinc oxide powder having average size in number of zinc oxide aggregates of at least 0.8 micrometer or at least 1 micrometer; and method of producing said powder.
BR112017000181A2 (en) process for producing an optical effect layer on a substrate, optical effect layer, its use and security document
BRPI0811730A2 (en) method and system for providing application privacy settings associated with network-based social media-readable member profile
AR098753A1 (en) PROCESSES TO PRODUCE LAYERS OF EFFECT
BR112017012363A8 (en) COATED MICROCAPSULES, THEIR USE AND THE CONSUMPTION PRODUCT THAT COMPRISES THEM
BRPI0813237B8 (en) compound, method of preparing the compound, medicine, and use of the compound
EA201000793A1 (en) PROPPANTS AND THEIR USE
MX2009005696A (en) Magnetic nanoparticles for the application in hyperthermia, preparation thereof and use in constructs having a pharmacological application.
CL2008001376A1 (en) Method for treating an underground formation comprising introducing into the fractures in the formation particles formed by a composite support agent, formed by a core of a support substrate having an adhered coating of magnetic particles.
BRPI1008633A2 (en) "a compound material comprising a metal and nanoparticles and a method for producing the same".
BRPI0718315A2 (en) APPLIANCE AND DISPERSION OF POWDER, METHOD OF MANUFACTURING AND USING THE APPLIANCE, AND COMPONENTS THAT MAY BE USED IN THE APPLIANCE AND OTHER DEVICES.
AR100088A1 (en) TREATMENT FLUID
MX2015016627A (en) VACCINE FOR MALARIA.
BR112017019050A2 (en) methane oxidation catalyst, process for preparing same and method for using the same
BR112014002036A2 (en) water fracture process containing particulate matter
CL2013002411A1 (en) Transparent, opacifying coating composition that provides brightness comprising nanoparticles that have an average d50 size of less than 1 micron and that are substantially dispersed in a binder; method for its formation; and use of said composition
BRPI1010808A2 (en) "computer-implemented method and system for posting selectively accessible content and content communication management method on social networking service"
BRPI0822907A2 (en) Computer implemented method, and computer readable medium
MX2009001663A (en) Rare earth nanoparticles.
BRPI0722259A2 (en) METHOD FOR PRODUCING AN ABSORBENT CLOTHING, AND ABSORBING CLOTHING PRODUCED IN ACCORDANCE WITH THE METHOD
AR080642A1 (en) SECURITY ELEMENTS, AND METHODS AND APPLIANCES FOR MANUFACTURING
CL2008002269A1 (en) Composition useful for treating plants, comprising an oily medium containing 1-methyl-cyclopropene particles encapsulated by an encapsulating agent, said particles being 50 microns or less and where the oily medium also comprises one or more dispersant.
BR112015013806A2 (en) adhesive composition, adhesive article and method for manufacturing a masking article
AR058037A1 (en) DISPERSION BY APPLICATION OF A METAL LAYER
BRPI1003281A2 (en) COMPOSITION AND METHOD FOR MAKING UP A KERATINIC SUBSTRATE